EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of CD8+ T Cells-Producing Interleukin 17 in Pathogenesis of Chronic Hepatitis B

Tégmaba Gnodja, Gnatoulma Katawa, Liza Koboyo Nadjir, Debehoma Venceslas Redah, Motomdéwa Monique Kadanga, Winiga Pauline Kowda, Hombamane Christelle Simfele, Minogblon Teko, Essimanam Rosalie Awesso, Aklesso Bagny, Manuel Ritter, Maléwé Kolou und 1 weitere

Open Journal of Immunology · 2026 · 16 (01) · 14-31

DOI: 10.4236/oji.2026.161002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Journal of Immunology, 2026. Verfasst von Tégmaba Gnodja und 12 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gnodja, T., Katawa, G., Nadjir, L. K., Redah, D. V., Kadanga, M. M., Kowda, W. P., Simfele, H. C., Teko, M., Awesso, E. R., Bagny, A., Ritter, M., Kolou, M., & Mbengue, B. (2026). The Role of CD8+ T Cells-Producing Interleukin 17 in Pathogenesis of Chronic Hepatitis B. Open Journal of Immunology, 16(01), 14-31. https://doi.org/10.4236/oji.2026.161002

Vancouver

Gnodja T, Katawa G, Nadjir LK, Redah DV, Kadanga MM, Kowda WP, et al. The Role of CD8+ T Cells-Producing Interleukin 17 in Pathogenesis of Chronic Hepatitis B. Open Journal of Immunology. 2026;16(01):14-31. doi:10.4236/oji.2026.161002

BibTeX
@article{Gnodja2026,
  author = {Gnodja, Tégmaba and Katawa, Gnatoulma and Nadjir, Liza Koboyo and Redah, Debehoma Venceslas and Kadanga, Motomdéwa Monique and Kowda, Winiga Pauline and Simfele, Hombamane Christelle and Teko, Minogblon and Awesso, Essimanam Rosalie and Bagny, Aklesso and Ritter, Manuel and Kolou, Maléwé and Mbengue, Babacar},
  title = {The Role of CD8+ T Cells-Producing Interleukin 17 in Pathogenesis of Chronic Hepatitis B},
  journal = {Open Journal of Immunology},
  year = {2026},
  volume = {16},
  number = {01},
  pages = {14--31},
  doi = {10.4236/oji.2026.161002}
}
Kostenlos starten →